Cargando…
Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record
Little is known about the difference in durability of HBsAg seroclearance induced by nucleoside analogs (NAs) or by interferon (IFN). A real-world, retrospective cohort study was conducted. Patients were assigned into two groups: NAs monotherapy-induced HBsAg seroclearance subjects and IFN monothera...
Autores principales: | Shi, Zongqi, Zheng, Huizhi, Han, Miaomiao, Hu, Jieli, Hu, Yuan, Li, Xiaosong, Zhu, Wenyan, He, Xinjun, Deng, Haijun, Long, Quanxin, Huang, Ailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308070/ https://www.ncbi.nlm.nih.gov/pubmed/37396526 http://dx.doi.org/10.1016/j.gendis.2022.03.003 |
Ejemplares similares
-
Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020) -
Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta‐analysis
por: Song, Aixin, et al.
Publicado: (2021) -
Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021) -
A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus
por: McCarthy, Stephen D. S., et al.
Publicado: (2016) -
2486. Clinical Outcomes of Patients Treated with Dolutegravir Functional Monotherapy or Dolutegravir plus an Active Non-cytosine Nucleoside Analog: A Retrospective Observational Cohort Study of Treatment-Experienced Patients
por: Rolle, Charlotte-Paige M, et al.
Publicado: (2019)